Cyclohexylpyrazole-Lactam Derivatives as inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1

يقدم الاختراع الحالي مركب جديد من الصيغه I: له تاثير فسيولوجي ل 11 B- HSD type 1 وكذلك طريقة تحضيره، وفي تجسيد اخر يقدم الاختراع تركيبات صيدلانية تتضمن مركبات من الصيغه I وكذلك طريقة استخدامه ومكوناته لعلاج داء السكري وارتفاع نسبة السكر بالدم والسمنة وارتفاع ضغط الدم وارتفاع نسبة الدهون بالدم واعراض...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Thomas Edward Mabry, Hongqi Tian, Leonard Larry Winneroski,Junior, Owen Brendan Waalace, Renhua Li, Alexei Pavlovych Krasutsky, Yanping Xu, Peter Biagio Anzeveno, Thomas Daniel Aicher, Ashraf Saeed, Gregory Alan Stephenson, Nancy June Snyder
Format: Patent
Sprache:ara ; eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Thomas Edward Mabry
Hongqi Tian
Leonard Larry Winneroski,Junior
Owen Brendan Waalace
Renhua Li
Alexei Pavlovych Krasutsky
Yanping Xu
Peter Biagio Anzeveno
Thomas Daniel Aicher
Ashraf Saeed
Gregory Alan Stephenson
Nancy June Snyder
description يقدم الاختراع الحالي مركب جديد من الصيغه I: له تاثير فسيولوجي ل 11 B- HSD type 1 وكذلك طريقة تحضيره، وفي تجسيد اخر يقدم الاختراع تركيبات صيدلانية تتضمن مركبات من الصيغه I وكذلك طريقة استخدامه ومكوناته لعلاج داء السكري وارتفاع نسبة السكر بالدم والسمنة وارتفاع ضغط الدم وارتفاع نسبة الدهون بالدم واعراض التمثيل الحيوي المضطرب، كما يعالج أي ظروف اخرى مصاحبة لنشاط 11 B- HSD type 1. The present invention discloses novel compounds of formula i Having 11B-HSD type 1 antagonist activity, as well as methods for preparing such compounds, in another embodiment, the invention discloses pharmaceutical compositions comprising compounds of formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11B-HSD type 1 activity.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JO3042B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JO3042B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JO3042B13</originalsourceid><addsrcrecordid>eNqFi0EKwjAUBbtxIeoRhFwgYKwnaFWKCG7cSvm2ryYQ-0t-KI2nV8G9q4EZZp7dytR4tpiSH1KgF3voMzWRnmqP4EaKboQoEuV66-4uchDFnTJGF4ikq9QGnpJEBHbt57Ff8UBPAmWW2awjL1j9uMjWx8O1rDQGriEDNegR69Ml3-y2hcn_9TdPKzqh</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cyclohexylpyrazole-Lactam Derivatives as inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1</title><source>esp@cenet</source><creator>Thomas Edward Mabry ; Hongqi Tian ; Leonard Larry Winneroski,Junior ; Owen Brendan Waalace ; Renhua Li ; Alexei Pavlovych Krasutsky ; Yanping Xu ; Peter Biagio Anzeveno ; Thomas Daniel Aicher ; Ashraf Saeed ; Gregory Alan Stephenson ; Nancy June Snyder</creator><creatorcontrib>Thomas Edward Mabry ; Hongqi Tian ; Leonard Larry Winneroski,Junior ; Owen Brendan Waalace ; Renhua Li ; Alexei Pavlovych Krasutsky ; Yanping Xu ; Peter Biagio Anzeveno ; Thomas Daniel Aicher ; Ashraf Saeed ; Gregory Alan Stephenson ; Nancy June Snyder</creatorcontrib><description>يقدم الاختراع الحالي مركب جديد من الصيغه I: له تاثير فسيولوجي ل 11 B- HSD type 1 وكذلك طريقة تحضيره، وفي تجسيد اخر يقدم الاختراع تركيبات صيدلانية تتضمن مركبات من الصيغه I وكذلك طريقة استخدامه ومكوناته لعلاج داء السكري وارتفاع نسبة السكر بالدم والسمنة وارتفاع ضغط الدم وارتفاع نسبة الدهون بالدم واعراض التمثيل الحيوي المضطرب، كما يعالج أي ظروف اخرى مصاحبة لنشاط 11 B- HSD type 1. The present invention discloses novel compounds of formula i Having 11B-HSD type 1 antagonist activity, as well as methods for preparing such compounds, in another embodiment, the invention discloses pharmaceutical compositions comprising compounds of formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11B-HSD type 1 activity.</description><language>ara ; eng</language><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160905&amp;DB=EPODOC&amp;CC=JO&amp;NR=3042B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160905&amp;DB=EPODOC&amp;CC=JO&amp;NR=3042B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Thomas Edward Mabry</creatorcontrib><creatorcontrib>Hongqi Tian</creatorcontrib><creatorcontrib>Leonard Larry Winneroski,Junior</creatorcontrib><creatorcontrib>Owen Brendan Waalace</creatorcontrib><creatorcontrib>Renhua Li</creatorcontrib><creatorcontrib>Alexei Pavlovych Krasutsky</creatorcontrib><creatorcontrib>Yanping Xu</creatorcontrib><creatorcontrib>Peter Biagio Anzeveno</creatorcontrib><creatorcontrib>Thomas Daniel Aicher</creatorcontrib><creatorcontrib>Ashraf Saeed</creatorcontrib><creatorcontrib>Gregory Alan Stephenson</creatorcontrib><creatorcontrib>Nancy June Snyder</creatorcontrib><title>Cyclohexylpyrazole-Lactam Derivatives as inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1</title><description>يقدم الاختراع الحالي مركب جديد من الصيغه I: له تاثير فسيولوجي ل 11 B- HSD type 1 وكذلك طريقة تحضيره، وفي تجسيد اخر يقدم الاختراع تركيبات صيدلانية تتضمن مركبات من الصيغه I وكذلك طريقة استخدامه ومكوناته لعلاج داء السكري وارتفاع نسبة السكر بالدم والسمنة وارتفاع ضغط الدم وارتفاع نسبة الدهون بالدم واعراض التمثيل الحيوي المضطرب، كما يعالج أي ظروف اخرى مصاحبة لنشاط 11 B- HSD type 1. The present invention discloses novel compounds of formula i Having 11B-HSD type 1 antagonist activity, as well as methods for preparing such compounds, in another embodiment, the invention discloses pharmaceutical compositions comprising compounds of formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11B-HSD type 1 activity.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFi0EKwjAUBbtxIeoRhFwgYKwnaFWKCG7cSvm2ryYQ-0t-KI2nV8G9q4EZZp7dytR4tpiSH1KgF3voMzWRnmqP4EaKboQoEuV66-4uchDFnTJGF4ikq9QGnpJEBHbt57Ff8UBPAmWW2awjL1j9uMjWx8O1rDQGriEDNegR69Ml3-y2hcn_9TdPKzqh</recordid><startdate>20160905</startdate><enddate>20160905</enddate><creator>Thomas Edward Mabry</creator><creator>Hongqi Tian</creator><creator>Leonard Larry Winneroski,Junior</creator><creator>Owen Brendan Waalace</creator><creator>Renhua Li</creator><creator>Alexei Pavlovych Krasutsky</creator><creator>Yanping Xu</creator><creator>Peter Biagio Anzeveno</creator><creator>Thomas Daniel Aicher</creator><creator>Ashraf Saeed</creator><creator>Gregory Alan Stephenson</creator><creator>Nancy June Snyder</creator><scope>EVB</scope></search><sort><creationdate>20160905</creationdate><title>Cyclohexylpyrazole-Lactam Derivatives as inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1</title><author>Thomas Edward Mabry ; Hongqi Tian ; Leonard Larry Winneroski,Junior ; Owen Brendan Waalace ; Renhua Li ; Alexei Pavlovych Krasutsky ; Yanping Xu ; Peter Biagio Anzeveno ; Thomas Daniel Aicher ; Ashraf Saeed ; Gregory Alan Stephenson ; Nancy June Snyder</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JO3042B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ara ; eng</language><creationdate>2016</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Thomas Edward Mabry</creatorcontrib><creatorcontrib>Hongqi Tian</creatorcontrib><creatorcontrib>Leonard Larry Winneroski,Junior</creatorcontrib><creatorcontrib>Owen Brendan Waalace</creatorcontrib><creatorcontrib>Renhua Li</creatorcontrib><creatorcontrib>Alexei Pavlovych Krasutsky</creatorcontrib><creatorcontrib>Yanping Xu</creatorcontrib><creatorcontrib>Peter Biagio Anzeveno</creatorcontrib><creatorcontrib>Thomas Daniel Aicher</creatorcontrib><creatorcontrib>Ashraf Saeed</creatorcontrib><creatorcontrib>Gregory Alan Stephenson</creatorcontrib><creatorcontrib>Nancy June Snyder</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Thomas Edward Mabry</au><au>Hongqi Tian</au><au>Leonard Larry Winneroski,Junior</au><au>Owen Brendan Waalace</au><au>Renhua Li</au><au>Alexei Pavlovych Krasutsky</au><au>Yanping Xu</au><au>Peter Biagio Anzeveno</au><au>Thomas Daniel Aicher</au><au>Ashraf Saeed</au><au>Gregory Alan Stephenson</au><au>Nancy June Snyder</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cyclohexylpyrazole-Lactam Derivatives as inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1</title><date>2016-09-05</date><risdate>2016</risdate><abstract>يقدم الاختراع الحالي مركب جديد من الصيغه I: له تاثير فسيولوجي ل 11 B- HSD type 1 وكذلك طريقة تحضيره، وفي تجسيد اخر يقدم الاختراع تركيبات صيدلانية تتضمن مركبات من الصيغه I وكذلك طريقة استخدامه ومكوناته لعلاج داء السكري وارتفاع نسبة السكر بالدم والسمنة وارتفاع ضغط الدم وارتفاع نسبة الدهون بالدم واعراض التمثيل الحيوي المضطرب، كما يعالج أي ظروف اخرى مصاحبة لنشاط 11 B- HSD type 1. The present invention discloses novel compounds of formula i Having 11B-HSD type 1 antagonist activity, as well as methods for preparing such compounds, in another embodiment, the invention discloses pharmaceutical compositions comprising compounds of formula I, as well as methods of using the compounds and compositions to treat diabetes, hyperglycemia, obesity, hypertension, hyperlipidemia, metabolic syndrome, and other conditions associated with 11B-HSD type 1 activity.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language ara ; eng
recordid cdi_epo_espacenet_JO3042B1
source esp@cenet
title Cyclohexylpyrazole-Lactam Derivatives as inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A05%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Thomas%20Edward%20Mabry&rft.date=2016-09-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJO3042B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true